Korczynski Sherry
SEC CIK 2026090 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | SVP Sales, Marketing | 244.4K | — | $111.3K | 11 | 2024-06-07 | 2026-09-09 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-11 11:07 | 2026-09-09 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | Chief Commercial Off | M - OptEx | $2.65 | +8,750 | 244.4K | +4% | +$23.2K |
| DT | 2026-09-11 11:07 | 2026-09-09 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | Chief Commercial Off | S - Sale+OE | $5.22 | -8,750 | 235.7K | -4% | -$45.7K |
| 2026-08-17 17:33 | 2026-08-14 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | Chief Commercial Off | F - Tax | $4.25 | -2,714 | 235.7K | -1% | -$11.5K | |
| 2026-06-09 14:48 | 2026-06-08 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | Chief Commercial Off | F - Tax | $0.00 | -2,714 | 238.4K | -1% | $0 | |
| D | 2026-03-11 | 2026-03-10 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | Chief Commercial Off | S - Sale | $4.17 | -15.7K | 241.1K | -6% | -$65.6K |
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | Chief Commercial Off | A - Grant | $0.00 | +75.0K | 256.9K | +41% | $0 |
| 2025-08-15 | 2025-08-14 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | Chief Commercial Off | A - Grant | $0.00 | +25.0K | 181.9K | +16% | $0 | |
| 2025-06-10 | 2025-06-09 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | SVP Sales, Marketing | F - Tax | $3.54 | -2,714 | 156.9K | -2% | -$9,608 | |
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | SVP Sales, Marketing | A - Grant | $0.00 | +90.0K | 165.0K | +120% | $0 |
| D | 2025-03-11 | 2025-03-07 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | SVP Sales, Marketing | F - Tax | $2.65 | -5,428 | 159.6K | -3% | -$14.4K |
| 2024-06-11 | 2024-06-07 | AQST | Aquestive Therapeutics, Inc. | Korczynski Sherry | SVP Sales, Marketing | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations